NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 22.382
EU - Europa 6.496
AS - Asia 4.577
SA - Sud America 62
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 33.549
Nazione #
US - Stati Uniti d'America 22.309
CN - Cina 2.249
IT - Italia 1.474
UA - Ucraina 1.305
DE - Germania 1.166
SG - Singapore 1.113
TR - Turchia 857
GB - Regno Unito 656
PL - Polonia 497
FI - Finlandia 452
SE - Svezia 417
ID - Indonesia 141
FR - Francia 113
BE - Belgio 111
VN - Vietnam 86
RU - Federazione Russa 70
CA - Canada 69
CZ - Repubblica Ceca 54
BR - Brasile 51
NL - Olanda 48
AT - Austria 33
RO - Romania 31
HK - Hong Kong 28
IR - Iran 28
LT - Lituania 27
IN - India 24
IE - Irlanda 11
KR - Corea 11
AU - Australia 9
CH - Svizzera 8
EU - Europa 8
JP - Giappone 8
AE - Emirati Arabi Uniti 5
TW - Taiwan 5
ES - Italia 4
GR - Grecia 4
PK - Pakistan 4
AR - Argentina 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
PT - Portogallo 2
AL - Albania 1
AO - Angola 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SN - Senegal 1
UY - Uruguay 1
Totale 33.549
Città #
Fairfield 2.943
Woodbridge 2.756
Houston 1.850
Chandler 1.546
Jacksonville 1.501
Ashburn 1.445
Ann Arbor 1.188
Santa Clara 1.115
Seattle 1.074
Wilmington 1.021
Cambridge 903
Singapore 837
Izmir 561
Warsaw 494
Beijing 476
Nanjing 467
Ferrara 364
Princeton 346
New York 326
San Diego 272
Boardman 243
Munich 217
Milan 209
Shanghai 204
Helsinki 164
Nanchang 140
Jakarta 139
Shenyang 129
Los Angeles 120
Bremen 110
Brussels 104
Dearborn 103
Tianjin 92
Addison 90
Falls Church 87
Dong Ket 81
Changsha 75
London 73
Hebei 71
Jiaxing 68
Jinan 63
Mountain View 61
San Mateo 55
Kunming 52
Redwood City 48
Brno 45
Washington 45
Norwalk 44
Bologna 43
Toronto 42
Rome 40
Ningbo 39
Zhengzhou 39
Guangzhou 37
Auburn Hills 34
Tappahannock 29
Verona 29
Philadelphia 28
Augusta 27
Frankfurt am Main 27
Hangzhou 26
Orange 26
Des Moines 25
Hong Kong 23
Vienna 23
Leawood 22
Ottawa 22
Hefei 21
Indiana 18
Naples 17
Nuremberg 17
Taizhou 17
Timisoara 17
Lanzhou 16
Napoli 16
Ardabil 15
Changchun 15
Monmouth Junction 13
Redmond 13
Amsterdam 12
Kilburn 12
Bari 10
Chicago 10
Dublin 10
Monte San Pietro 10
Falkenstein 9
Ferrara di Monte Baldo 8
Haikou 8
Palermo 8
San Jose 8
Acton 7
Lappeenranta 7
San Giorgio Di Piano 7
Trieste 7
Hounslow 6
Pavia 6
Prescot 6
San Francisco 6
Wuhan 6
Cleveland 5
Totale 25.361
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 547
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 296
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 233
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 197
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 193
Absolute quantification of cell-free microRNAs in cancer patients 192
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 191
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 189
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 189
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 184
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 174
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 172
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 171
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 166
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 157
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 157
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 156
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 155
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 155
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 154
MicroRNA e cancro 152
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 151
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 146
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 146
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 143
MicroRNA involvement in hepatocellular carcinoma 142
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 141
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 140
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 138
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 138
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 138
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 138
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 137
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 137
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 137
Circulating non-coding RNA as biomarkers in colorectal cancer 137
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 137
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 136
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 135
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 135
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 135
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 134
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 133
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 133
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 133
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 133
null 132
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 132
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 132
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 129
null 128
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 128
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 128
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 128
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 127
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 127
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 127
Tumor suppressor functions of ARLTS1 in lung cancers 127
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 127
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 126
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 126
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 124
Reprogramming of miRNA networks in cancer and leukemia 123
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 122
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 122
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 121
MicroRNA response to environmental mutagens in liver 120
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 119
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 119
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 119
Extensive modulation of a set of microRNAs in primary glioblastoma 118
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 118
Animal Models of Hepatocellular Carcinoma Prevention 118
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 117
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 117
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 117
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 117
MicroRNA deregulation in human thyroid papillary carcinomas 117
Evidence for BK virus as a human tumor virus 116
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15) 116
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 116
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 116
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 115
Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia 115
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 115
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 115
Regulatory mechanisms of microRNAs involvement in cancer 115
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 114
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 114
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 113
Evidence for BK virus as a human tumor virus. 113
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 113
A microRNA signature of hypoxia 113
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 113
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 113
Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy 112
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 112
Totale 14.138
Categoria #
all - tutte 162.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.648
Totale 169.479


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.049 0 0 0 0 0 0 632 676 571 697 293 180
2020/20214.955 399 436 345 503 209 470 202 510 126 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20253.544 188 179 650 350 1.005 859 313 0 0 0 0 0
Totale 34.053